Previous 10 | Next 10 |
2023-07-11 18:12:17 ET SuRo Capital ( NASDAQ: SSSS ) on Tuesday said it held positions in 37 portfolio companies as of Q2, unchanged from Q1. Of the 37 firms, 33 are privately held and 4 are public companies. The company also anticipates its net asset value as of June ...
NEW YORK, July 11, 2023 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS ) today provided the following preliminary update on its investment portfol...
2023-07-05 17:32:16 ET Gainers: Cardlytics, Inc. ( NASDAQ: CDLX ) +9% . Autolus Therapeutics ( AUTL ) +5% . Omeros ( OMER ) +4% . Arrival ( ARVL ) +3% . Nkarta ( NKTX ) +3% . Losers: IDEAYA Biosciences ( IDYA ...
2023-05-25 10:40:00 ET Summary SuRo Capital is down around 17% year-to-date with its discount to net asset value moving to 57%. The composition of the equity-focused BDC's portfolio is broadly unchanged from last year as continued macroeconomic headwinds continue to pressure tech ...
2023-05-09 22:45:02 ET SuRo Capital Corp. (SSSS) Q1 2023 Earnings Conference Call May 9, 2023 5:00 PM ET Company Participants Willy Lee – Investor Mark Klein – Chairman and Chief Executive Officer Allison Green – Chief Financial Officer ...
2023-05-09 16:37:08 ET SuRo Capital press release ( NASDAQ: SSSS ): Q1 GAAP NII of -$0.15 misses by $0.04 . Total investment income of $1.3M (+124.1% Y/Y) misses by $0.35M . For further details see: SuRo Capital GAAP NII of -$0.15 misses by $0.04, To...
NEW YORK, May 09, 2023 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS ) today announced its financial results for the quarter ended March 31, 2023...
NEW YORK, May 02, 2023 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”) ( Nasdaq: SSSS ) today announced that it will report its financial results for the quarter ended March 31, 2023 after the close of the U.S. market on Tuesday, May 9, 2023. Ma...
2023-04-10 08:49:00 ET SuRo Capital ( NASDAQ: SSSS ) anticipates Q1 net asset value to be approximately $7.35 to $7.85 per share against $7.39/share at December 31, 2022 and ~$380.7M, or $12.22/share at March 31, 2022. As of March 31, 2023, the Company had 28,338,580 shares of...
Net Asset Value Anticipated to be $7.35 to $7.85 Per Share Tender Offer Expiring on April 17, 2023 at 5:00 P.M. Eastern Time NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, ...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS ) today provided the following preliminary update on its investment...
Net Asset Value of $7.17 Per Share as of March 31, 2024 Completed $35 Million in New Investments Year-to-Date NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”,...
NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”) ( Nasdaq: SSSS ) today announced that it will report its financial results for the quarter ended March 31, 2024 after the close of the U.S. market on Wednesday, May 8, 2024. Mana...